2026 NIAID DMID Omnibus Broad Agency Announcement
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Contract Value
Not provided
Codes & Classification
Solicitation Number
HHS-NIH-NIAID-BAA2025-1
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN12
Additional Details
The 2026 NIAID DMID Omnibus Broad Agency Announcement represents a significant procurement initiative by the National Institutes of Health (NIH), specifically through its National Institute of Allergy and Infectious Diseases (NIAID). This award notice, identified by procurement number HHS-NIH-NIAID-BAA2025-1, signals the completion of a cost-reimbursement contract under full and open competition. The selection of a cost-reimbursement contract underscores the inherent complexity and unpredictability of the research activities involved, as costs could not be precisely determined at the time of award.
The scope of this contract is classified under NAICS code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (excluding nanotechnology and biotechnology). This classification suggests that the contract is intended to support advanced research efforts in these scientific domains, likely encompassing a broad range of investigative and developmental activities. The associated Product Service Code AN12 further indicates a focus on research and development services.
The primary objectives of this procurement are to advance scientific knowledge and innovation within the physical, engineering, and life sciences, aligning with NIAID’s mission to address critical health challenges. Contractors are expected to deliver high-quality research outcomes, contribute to the development of new methodologies or technologies, and support the overarching goals of the Department of Health and Human Services (HHS) and NIH.
The contracting entity is the NIH NIAID, a federal office within the Department of Health and Human Services. The primary point of contact for this opportunity is Swee L. Teo, who can be reached via email at [email protected] or by phone at 240-669-5173. The notice remains active as of the posting date, March 8, 2026, and is accessible through the SAM.gov portal (Opportunity ID: 933e442e3d3c401e96446236109997d3).
This procurement was conducted without set-aside requirements, reflecting its full and open competition status. There are no special considerations or attachments noted in the announcement. Contractors evaluating this opportunity should be prepared for the dynamic nature of cost-reimbursement contracts and possess robust capabilities in research and development within the specified scientific fields. The contract’s fundamental elements—its focus on advancing R&D in physical, engineering, and life sciences, its federal sponsorship, and its open competition framework—will remain constant throughout its lifecycle.
For further information or to review the official notice, interested parties are encouraged to visit the SAM.gov listing at https://sam.gov/opp/933e442e3d3c401e96446236109997d3/view.